Oncternal Therapeutics Announces Presentation of Case Study of TK216 in Ewing Sarcoma Given at the Children?s Oncology Group Meeting

San Diego Biotechnology Network
San Diego Biotechnology Network
Oncternal Therapeutics Announces Presentation of Case Study of TK216 in Ewing Sarcoma Given at the Children?s Oncology Group Meeting
Loading
/

SAN DIEGO–(BUSINESS WIRE)–Oncternal Therapeutics Announces Presentation of Case Study of TK216 in Ewing Sarcoma. Given at the Children?s Oncology Group Meeting